Modern method treatment castration-refractory prostate cancer
Автор: Abdulazizov S.A.
Журнал: Экономика и социум @ekonomika-socium
Рубрика: Основной раздел
Статья в выпуске: 11-1 (90), 2021 года.
Бесплатный доступ
Long-term treatment in patients with castration-refractory prostate cancer was extremely symptomatic and quality of life and overall survival were low. In the 2000s, investigations aimed at designing drugs to treat this category of patients were underway, which have culminated in the advent of three drugs (two of which belong to chemotherapy) that are now used in the world.
Castration-refractory prostate cancer, intracrine synthesis of testosterone, hypersusceptibility of tumor receptors, hyperproduction of tumor receptors.
Короткий адрес: https://sciup.org/140261005
IDR: 140261005
Список литературы Modern method treatment castration-refractory prostate cancer
- Gritskevich A.A. Clinical evaluation of various variants of drug therapy for hormone-resistant prostate cancer // dis.... Candidate of Medical Sciences: 14.00.12.2011. - p.192.
- Petrov S.B.N., A.K.; Vorobyev, N.A. New drugs in the therapy of prostate cancer resistant to castration // Sovr. oncol. 2011. Vol.3. - p.55-61
- And Skvortsov.Ya., Kamolov B.Sh., Hafizov K.O., And Pavlovskaya.I., Vishnevskaya Ya.V., Gutorov S.L., K. Figin.M., V. Matveev.B. Neuroendocrine prostate cancer (description of a clinical case) // Oncourology. 2011. Vol. 2. - pp. 92-95.
- Angelerg A., Maye D., Flechon A., Ozguroglu M., Mercier F., Guillot A., Le Moulec S., Gravis G., Buzebok P., Massard S., Fizazi K., de La Motte Rouge T., Delanoy N., Elaidi R.T., Udar S. Outbreak of prostate-specific antigen induced by cabazitaxel-based chemotherapy in patients with metastatic castrationresistant prostate cancer/ / Eur J Cancer. 2014. Vol.50. No. 9. - pp. 1602-9.
- Goodman O.B., Jr., Flyg T.U., Molina A., Mulders P.F., Fizazi K., Suttmann H., Lee J., Heoh T., de Bono J.S., Sher H.I. Research analysis of a subgroup of visceral diseases in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer// Prostate cancer. 2014. Vol. 17. No. 1. - pp. 34-9.
- Yap T.A., Pesaro K.J., de Bono J. S. Kabazitaxel in metastatic castrationresistant prostate cancer// An expert in the fight against cancer. 2012. No. 12. No. 9. - pp. 1129-36.
- Z. Zafeiriou, R. Ferraldeschi, A. G. Omlin, S. Pesaro, D. Mukherjee, D. Lorente, A. Altavilla, S. Sideris, P. Resquinho, J. Mateo, D. Biancini, A. Smith, R. Perez Lopez, N. Mehra, P. Ravi, E. Grist, N. Tunariu, G. Attard, Bono J. S.D. Sequencing of docetaxel (D) and acetate abiraterone (AA) in metastatic castration-resistant prostate cancer (mCRPC)//Annals of Oncology: The official Journal of the European Society of Medical Oncology. 2014. T. ESMO 2014: 25 (Supplement 4 summary 791P).
Статья научная
